FDA Approved: BELSOMRA — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for BELSOMRA (suvorexant) from Merck Sharp & Dohme LLC, resulting in an updated labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Belsomra (suvorexant)

Snippet

SUPPL AP for BELSOMRA (SUVOREXANT)